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Strengths and limitations of this study
 ► This is a systematic literature review that follows the 
Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses guidelines.
 ► The protocol was published before conducting the 
study to avoid data-driven decisions.
 ► A comprehensive literature search was carried 
out using eight major research paper databases, 
hand-searching and snowballing.
 ► All included studies were quality assessed using 
well-cited tools and documentation.
 ► A study limitation is that only studies that were pub-
lished in English language were included.
AbStrACt
Objectives This systematic literature review aims to 
identify important design features of the electronic 
personal health record (PHR) that may improve medication 
adherence in the adult population with long-term 
conditions.
Data sources PubMed (including MEDLINE), CINAHL, 
Science Direct (including EMBASE), BioMed Central, ACM 
digital, Emerald Insight, Google Scholar and Research 
Gate.
Methods Studies that were published between 1 
January 2002 and 31 May 2018 in English were included 
if the participants were adults, with at least one long-
term condition, were able to self-administer their 
medication and were treated in primary care settings. 
The quality of evidence was assessed with the Grading 
of Recommendations Assessment, Development, and 
Evaluation (GRADE) system and the risk of bias was 
appraised using the Cochrane risk of bias tool.
results From a total of 27 studies that matched the 
inclusion criteria, 12 were excluded due to low quality of 
evidence, 10 were rated moderate and 5 were rated high 
quality. All the included studies had low sample size and 
limited follow-up duration. Thirteen of the included studies 
found that the use of a PHR has increased medication 
adherence. The identified design features are reminders, 
education, personalisation and tailoring, feedback and 
alerts, gamification, medication management, medical 
appointment management, diary and self-monitoring, 
health condition management, set goals, patient’s blog 
and tethered. It was impossible to draw conclusions as 
to which feature is important to what group of patients 
and why. The most frequently identified conditions were 
HIV and diabetes. This review did not identify any papers 
with negative results. It was not possible to numerically 
aggregate the PHR effect due to high heterogeneity of 
the medication adherence measurement, study type, 
participants and PHRs used.
Conclusion Although we found recurrent evidence 
that PHRs can improve medication adherence, there is 
little evidence to date to indicate which design features 
facilitate this process.
PrOSPErO registration number CRD42017060542.
IntrODuCtIOn
A 2018 healthcare consultant report calls 
for focusing on healthcare value instead of 
increasing the size of the current systems 
to accommodate for the rising demand.1 
Healthcare expenditures were 16.5% of 
gross domestic product (GDP) in USA and 
11.5% of GDP for Switzerland in 2016.1 NHS 
policy anticipates that increasing usage of 
health apps by patients will reduce demand 
on healthcare services.2 The NHS Long Term 
Plan3 policy document focuses on increasing 
personalisation in healthcare to improve 
quality of life and public health and aspires 
that information and communication tech-
nology (ICT) can reduce healthcare costs 
and improve healthcare outcomes over the 
next 5 years. This assertion, however, is not 
based on scientific research, so the claimed 
benefits remain aspirational.
Currently, 74% of UK nationals older than 
45 years old and almost all younger adults less 
than 45 years old are using the internet nearly 
every day.4 Based on the results of a 2017 US 
survey, roughly 40% of people living with a 
long-term condition were interested in using 
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technology to assist them with medication, diagnosis, 
test results and managing their condition in their home 
environment.5
A form of ICT that could potentially benefit the patients 
and the healthcare services is the electronic personal 
health record (PHR). A PHR has been defined as “online 
systems that include collections of patients’ healthcare 
and medical data, which use health informatics standards 
to enable patients to share, organize and manage these 
data according to their own views”.6 Some of the claimed 
benefits of PHRs are the ability of PHR to improve patient 
outcomes, decrease care cost, allow patients the ability to 
self-manage their health, increase access to care especially 
in remote areas, empower patients and improve medica-
tion adherence.7 8
Medication adherence is a well-known challenge in 
healthcare9 10 and is related to a large number of factors 
such as side effects,11 forgetfulness9 or effective self-man-
agement12 and is affected by psychological factors and 
beliefs.12 Medication adherence can be defined as ‘the 
extent to which a person’s behaviour towards their medi-
cation intake, corresponds with agreed recommenda-
tions from a health care provider’.10 The WHO reported 
that in developed countries the medication adherence 
in patients with long-term conditions averages to 50%.13 
There is limited evidence whether PHRs actually improve 
medication adherence in chronically ill adults and no 
evidence synthesis as to which PHR design features are 
the most effective.
Polypharmacy refers to the simultaneous use of multiple 
medications and has been associated with several poor 
health outcomes including medication adherence.14–16 
The effects of poor medication adherence are greater for 
people with polypharmacy.16 The effect is greater since 
the number of people with multiple long-term condi-
tions is also rising.17 It is estimated that in UK, more than 
one-third of patients with at least one long-term illness do 
not adhere to their medication regime.18
A number of systems are currently in practice to use ICT 
in order to store, manage and employ health and medical 
information. These ICTs are developed by coders who are 
implementing human–computer interaction (HCI) prin-
ciples.19 The HCI discipline is used to improve the usability 
of the software to developers, especially in healthcare 
settings.20 The NHS standards for PHRs21 provide guid-
ance on good practice for their development in England, 
but they do not provide enough details or guidelines on 
what design features should a PHR include nor evidence 
on how these features impact health outcomes.
Although a number of strategies and interventions 
have been identified to assist patients’ medication adher-
ence,22 23 the number of approaches related to PHRs 
is surprisingly low. This is surprising since the limited 
success that traditional approaches to support adherence 
have had and that technical interventions may easily be 
combined with other categories of interventions such as 
behavioural to address and potentially improve medica-
tion adherence.24
This is the first systematic literature review that aims to 
identify important design features of the PHR that may 
improve medication adherence in the adult population 
with long-term conditions.
Objectives
Primary objective
Identify the important design features of the PHR that 
may have improved medication adherence in the adult 
population with long-term conditions.
Secondary objectives
 ► Identify the PHR design features that may have 
improved medication adherence in the cases of:
 – polypharmacy;
 – specific long-term condition groups.
 ► Identify if there was a correlation between partici-
pants’ demographic characteristics, their usage of 
PHRs and their medication adherence.
 ► Explore how implementation factors affected medica-
tion adherence.
MEthODS
This systematic review is registered in the prospective 
register of systematic reviews (PROSPERO) and it follows 
the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines.25 The PRISMA 
checklist is provided as an online additional file. The 
protocol for this study is published.6
Study eligibility and selection
The inclusion and exclusion criteria of this review are 
illustrated in table 1 and are detailed in the published 
protocol.6 As a result of the peer-review process, we have 
decided to make a change in our published protocol and 
to exclude systematic literature reviews and include only 
primary studies.
There have been no deviations from the protocol.
Literature search
Mendeley software26 was used as the bibliographic soft-
ware. One author (EA) scanned the titles and abstracts 
and excluded studies that clearly did not meet the inclu-
sion criteria. Full-text versions of the remaining articles 
were obtained and screened by the same author, using 
the criteria listed on table 1. All the excluded studies were 
listed with at least one reason for exclusion. In case of 
uncertainty, the author PS was advised and there was a 
discussion until an agreement was made. The reference 
lists of the included studies were examined to identify 
additional relevant literature. A hand-search of JMIR 
Medical Informatics, BMC Medical Informatics and Decision 
Making and BMJ Open was conducted by EA to identify 
further literature, as they were the three most cited and 
most impactful journals in the search we had done.
The full search strategy can be found in online supple-
mentary file. The search dates are from 1 January 2002 to 
31 May 2018 and the search terms are:
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Table 1 Summary of the PICOS elements included and excluded in the systematic review
Inclusion criteria Exclusion criteria
Participants Humans
Adults with at least one long-term condition
Patients who can self-administer their medication
Patients who are able to communicate freely and able 
to self-manage their medication
Patients who are treated outside the hospital only
Animals
Pregnant, cancer or terminally ill patients
Adults with medically serious problems that are 
not classified as long-term conditions
Patients who require assistance in taking their 
medication
Patients who are unable to communicate or 
unable to self-manage their medication
Inpatients or patients who are living in care homes
Intervention Interventions of any type, intensity and frequency, 
which aim to investigate the effect of electronic PHRs 
in medication adherence, concordance, compliance or 
persistence
N/A
Comparators Non-PHR No comparison has been made with non-PHR or 
with usual care
Outcome Any outcome related to the effect of electronic PHRs 
in medication adherence, concordance, compliance or 
persistence.
N/A
Study design/type Primary studies published in the last 15 years, without 
any geographical restriction
Abstract-only reports without any references, 
commercial studies, party political statements, 
general discussion papers, magazine or 
newspaper articles, withdrawn abstracts or 
articles, protocols of reviews or literature reviews
Quality of the 
studies
Studies with moderate or high quality Studies with low and very low quality
PHR, personal health record.
(phr OR “personal health record” OR “patient portal”) 
AND adult* AND (“chronic disease” OR “chronic illness” 
OR “chronic condition” OR “long term disease” OR “long 
term illness” OR “long term condition”) AND (“medica-
tion compliance” OR “medication adherence” OR “medi-
cation concordance” OR “medication persistence”)
Data extraction and analysis
EA reviewed and extracted all literature and the data 
in the predefined data extraction forms.6 The data 
extraction forms were designed by PS and EA to collect 
all the necessary data, based on the National Institute for 
Health and Care Excellence data extraction forms27 and 
the research questions. The completed data extraction 
forms, the initial and complete narrative analysis of the 
generated data were performed by EA and face-validated 
by PS6 who did not review the excluded literature.
Quality assessment
The quality of all included studies was assessed by the 
first author (EA) and 25% of the included studies were 
assessed by the second author (PS). Cohen’s Kappa 
(k) inter-rater reliability measure28 was calculated. The 
Joanna Briggs Institute (JBI) critical appraisal question-
naires were used to implement the GRADE approach29 of 
quality assessment of the included studies. The GRADE 
approach is proposed by the Cochrane Collaboration30 
and it favours the JBI critical appraisal tools.31
The final quality scores per paper (table 2) were 
assigned based on five factors: risk of bias,32 inconsis-
tency,33 indirectness,34 imprecision35 and publication 
bias.36 All the studies were graded based on their study 
type, for example, randomised controlled trials (RCTs) 
and systematic literature reviews were stated as high 
quality studies. Using the GRADE categories, we started 
from the highest possible score based on the study type, 
using the JBI questions to extract data per paper for the 
GRADE scoring, reducing the quality for each instance of 
the factors mentioned above.
Patient and public involvement
Patient and public involvement (PPI) has already been 
involved in the design of this research. On 22 June 2018, 
a PPI focus group with eight participants took place at the 
University of Portsmouth. The suggestions of this group 
are taken into consideration by the research team. The 
PPI group approved the focus of this review and provided 
guidelines for future research.
rESuLtS
Literature search results
Figure 1 illustrates the literature search and selection 
method, presenting explanations for the exclusion 
of studies. Once duplicates were removed, a total of 
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Figure 1 Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses literature search and selection method 
diagram.
Table 3 PHR design features
Feature Definition
Medication adherence 
results by study
Positive No difference
Reminder Reminders to take medication or to reorder their prescriptions, agnostic to 
the patient’s chronic condition, demographics or any other external factor.
11 1
Education Includes smaller features, like search bars and views, which can improve 
the user’s health literacy and understanding of their condition.
3 2
Personalisation and tailoring The personalisation involves presenting a health message specific to 
the individual patient’s condition and demographic characteristics, 
while tailoring involves developing a PHR based on the individual’s 
characteristics.69
8 1
Feedback and alerts Medical emergency alerts in the form of a press button alert or SMS, such 
as the ones a user may find in the MyALERT PHR.70
10 2
Gamification An umbrella term that includes the use of game design characteristics in 
non-game contexts.71
4 1
Medication management Includes all the features that a chronically ill patient may need to conform to 
everyday life.72
10 2
Medical appointment 
management
Medically related appointment tracking, re-scheduling and arrangement.73 2 –
Diary and self-monitoring A combination of features related to health or medication intake 
monitoring.74
8 2
Health condition 
management
Includes all the lab and medical tests results and integration of existing 
clinical data.69
3 1
Set goals Includes all the elements that are necessary for setting and managing goals. 2 1
Patient’s blog Includes sharing in social media or blogging regarding health.40 1 –
Tethered Are the PHRs which are connected with an EHR.75 2 –
EHR, electronic health record; PHR, personal health record .
1787 original works were identified and 15 were finally 
included in the qualitative synthesis.
Characteristics of included studies
This review includes studies conducted in the USA (n=7), 
Switzerland (n=2), Canada (n=1), UK (n=1), Germany 
(n=1), Italy and Czech Republic (n=1), New Zealand 
(n=1) and Spain (n=1). Most studies had included partic-
ipants who have at least one long-term condition (n=9), 
diabetes (n=4) and HIV (n=3). Studies were published in 
2017 (n=4), 2014 (n=4), 2016 (n=3), 2015 (n=2), 2013 
(n=1) and 2008 (n=1). The majority of the included 
studies (n=13) reported a positive result in terms of the 
impact on medication adherence, with two studies found 
no difference.37 38 No study identified negative results. 
Five out of 5 high quality studies and 8 out of 10 moderate 
quality studies found positive results with medication 
adherence. The main study characteristics are illustrated 
in table 2.
Primary objective
Table 3 presents the PHR design features that were iden-
tified in the literature and are the generated themes of 
this literature review. The definitions of the PHR design 
features were derived from commercial PHRs that are 
implementing them or the wider literature regarding 
PHRs and personal experience, since there are no 
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International Standards Organization standards or 
universally accepted terminology.
All the PHR design features, which constitute the 
themes derived from our thematic analysis,39 are inter-
linked and overlapped. NVivo V.11 was used to cluster our 
codes potentially into more comprehensive themes. The 
initial themes were clustered together based on coding 
similarity, which means that if they were coding many 
of the same included studies, then they were clustered 
together.
 ► Reminder and medical appointment management 
(used in two studies).
 ► Tethered (used in two studies).
 ► Diary and self-monitoring (used in 10 studies).
 ► Feedback and alerts and health condition manage-
ment (used in four studies).
 ► Medication management and patients blog (used in 
one studies).
 ► Personalisation and tailoring, gamification, educa-
tion, set goals (used in 10 studies).
Secondary objectives
PHR design features that improve medication adherence in case of 
polypharmacy
Although multiple papers include polypharmacy or multi-
morbidity factors about their participants, they do not 
explore whether there is a correlation or an association 
between polypharmacy and the PHR usage or whether 
there is a medication adherence improvement or not. 
There is a trend that the more medications a person uses 
the less a reminder helps. This is not a conclusion directly 
supported by the data, but an argument emerging from 
multiple studies.38 40–42
PHR design features that improve medication adherence for 
specific long-term condition groups
This research identified a number of chronic conditions. 
However, diabetes and HIV can only be used to analyse 
the impact that the PHR design features are having in 
medication adherence, since the rest of the conditions 
are included in just one study.
HIV
Three studies have been included which discuss how 
the use of PHRs affect medication adherence of adults 
with HIV.42–44 All three studies produced positive results, 
having a very small (less than 50) number of participants 
who are also predominantly men and younger than 
50 years old. Two studies are RCTs,43 44 having follow-up 
duration of 2–3 months and the other one is a qualitative 
study42 without any follow-up. All three studies include 
the personalisation and tailoring design feature, two of 
the studies use reminders, one study uses feedback and 
alerts and health condition management and one other 
study uses diary and self-monitoring design feature.
Diabetes
Four studies have been included which discuss how the 
use of PHRs affect medication adherence of adults with 
diabetes.37 45–47 All studies found positive results regarding 
medication adherence, apart from Glasgow et al.37 Three 
studies used diary and self-monitoring37 45 46 or personal-
isation and tailoring,37 45–47 three studies used education 
and set goals37 45 46 or gamification37 45 47 and one46 study 
used feedback and alerts and health condition manage-
ment PHR design features. The follow-up duration of 
studies was 12 months apart from Fioravanti et al,45 which 
was 1 month.
Association between participants’ demographic characteristics, 
their usage of PHRs and their medication adherence
Data regarding patients’ demographics and medica-
tion adherence were collected and analysed. Only 243 48 
of the 15 studies provide a detailed description of the 
participants’ ethnicity. Two studies48 49 also provide data 
regarding the technology literacy of the participants and 
two other studies37 43 provide data for the health literacy 
of the participants.
Twelve of the 15 studies provided age group details, 
which illustrate that the younger the participants, the 
more positive results regarding medication adherence 
were identified. This could be due to the presumed 
technological literacy of younger generations, however 
it was impossible to account for this confounding factor, 
since no data were supplied. Also the lower the number 
of participants in an experimental study (less than 251), 
the higher the impact of PHR in medication adherence. 
This could arguably illustrate a case of confirmation bias, 
meaning that the researcher stopped recruitment when 
the hypothesis was verified. It could also mean that some 
of these results are less accurate, due to lower number 
of participants, since there is uncertainty towards the 
validity of the results derived from RCTs with less than 
100 participants.50
How implementation factors affect the outcomes and 
heterogeneity
Heterogeneity has been found in the included studies 
regarding the study location, the included long-term 
conditions and the medication adherence measurement 
method. Although the included study types were also 
heterogenic (table 2), this does not seem to affect the 
general trend that the use of PHR has a positive impact in 
medication adherence. Heterogeneity has also been iden-
tified in participants’ demographics and confounding 
factors (table 2).
Although expected otherwise, the duration of the 
follow-up in RCT studies does not seem to affect the 
outcomes, since the majority of the included RCTs 
produced positive results. There is however an indication 
that three out of four RCT studies that did not produce 
positive results had 12 months follow-up. This observa-
tion is in-line with the general idea of the field being new 
and there are no global standards that dictate the design 
of PHRs. Another interesting fact is that the studies that 
were either observational or literature reviews produced 
statistically more positive results than the RCTs.
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Figure 2 Overall risk of bias.
Quality assessment
The inter-rater reliability for quality assessment was calcu-
lated k=0.88, which indicates high reliability of the quality 
assessment. Overall, 27 studies matched our inclusion 
criteria. Twelve of these studies were excluded due to 
low quality of evidence, 5e were graded as high quality of 
evidence and the remaining 10 were graded as moderate 
quality of evidence. The detailed quality assessment table 
based on the GRADE approach can be found in the 
online supplementary file 1.
Figure 2 illustrates the overall risk of bias for this study. 
The details behind this diagram and the overall quality 
assessment are provided as additional file.
DISCuSSIOn
In this section, we reflect on the principal themes and 
overall conclusions from the literature review. The first 
impression after the initial data analysis was that too few 
studies actually mentioned the term PHR. In the majority 
of the cases, we had to critique the intervention of the 
inclusion criteria based on our PHR definition. This 
systematic review included 15 primary studies of multiple 
study types and identified 12 different PHR design 
features. Although 12 different PHR design features 
were identified, there are no specific guidelines that can 
be derived from the results. Overall, 87% (n=13) of the 
included studies found that the use of a PHR has increased 
medication adherence. Based on the number of studies 
that identified positive results, the fact that 8 out of the 
10 high quality studies identified positive results and that 
no study indicated a negative effect on medication adher-
ence, we conclude that there is a reasonable indication 
that PHRs can have an overall positive effect on medica-
tion adherence. However, due to the high heterogeneity 
in medication adherence measurements, reporting styles 
and study types, we were unable to group and quantify 
the results in study level. It is of course possible that the 
absence of negative results is due to publication bias.
Reminders, feedback and alerts and medication 
management are the most commonly used PHR design 
feature, since all studies include at least one of the three 
features. These findings are also consistent with the 
existing literature, which identifies reminders, and medi-
cation management as the most commonly used features 
that assist patients with their medication intake.51–55 The 
design features with the most positive effect for patients’ 
medication adherence were patient’s blog, tethered and 
medical appointment management. This could be argu-
able since these features are also the least used, since 
the medication appointment management has the most 
positive results in the relevant literature.52–58 The gener-
ated clusters paint a similar picture. The cluster that 
produces the best results is personalisation and tailoring, 
gamification, education and set goals (92% of studies in 
this cluster produce positive results) and reminder and 
medical appointment management (80% of studies in 
this cluster produce positive results).
Two groups of patients have been identified in this 
literature review for further analysis to find which of 
the PHR design features work best for them. The most 
positive results for diabetic participants were identi-
fied by three studies45–47 that used PHRs. Furthermore, 
for participants with HIV, three studies were identified 
producing positive results42–44 that used at least personali-
sation and tailoring design feature and reminders. Mixed 
associations were found between patients demographics, 
their PHR usage and medication adherence. Taking into 
account the median age confounding factor of the partic-
ipants, it is apparent that the younger the participants, 
the more positive are the results. This is also supported in 
the general academic literature that suggests that techno-
logical literacy levels are higher in younger adult popula-
tion.59 60
Furthermore, the less participants a study included 
the more positive the results appeared to be. This in fact 
may cause problems in the quality of evidence for the 
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included studies and this literature review; hence our 
suggestion is to interpret the results with caution. There is 
a proven link between the sample size of an RCT and the 
statistical significance of its result.61 According to Faber 
and Fonseca,62 the small sample size might increase the 
chance of false-positive and the study might not reach to 
an evident conclusion.
The ‘other’ bias category has the highest risk of bias of 
all the assessed risks, which is in line with the key findings 
of this and other related studies,63 resulting in a probable 
overestimation of PHR effect on medication adherence 
and potentially echoing a form of recall bias.64 Although 
some degree of bias is considered unavoidable, the high 
risk of bias identified in the included studies and the 
generally moderate quality of evidence presented in them 
also reflect the uncertainty on this field and the need for 
further research on both PHRs and medication adher-
ence. A PHR design feature that is not mentioned in the 
included literature is security. This might be happening 
due to the inclusion/exclusion criteria of this systematic 
review, since the security of the data does not seem to 
affect patients’ medication adherence. Another limita-
tion is that we included English papers published in the 
last 15 years, due to time and cost constraints. Screening 
of the studies and data collection were conducted by 
EA and only face-validated by PS, therefore this is also a 
significant limitation. Furthermore, the small number of 
participants in the studies is commonly known to over-
estimate the effect of an intervention, the fact which is 
noticeable in the included studies.
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